Better care for heart and liver transplant recipients
Part of Cancer, Digestive system clinical trials.
This study uses computer algorithms, biological markers, and surveys about well-being to create personalized care plans for people who have received a heart or liver transplant. It aims to find better ways to monitor and manage your health after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You received a heart or liver transplant at the study hospital in Bologna, Italy, between 2008 and 2020.
- You have survived at least 6 months after your transplant surgery.
- You have had at least one follow-up clinic visit that included a check-up, blood tests, and an ultrasound of your new organ.
- Your medical records are available in the hospital's electronic system. (If your records are missing, you cannot take part in this part of the study.)
- For the second part of the study, you must be willing and able to sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a database of people with severe liver problems or who have had a liver transplant. The goal is to learn more about these conditions and improve care.
This trial tests whether an artificial intelligence system can help detect liver cancer recurrence earlier after curative treatment, allowing for potentially curative salvage therapy. Participants who have undergone complete surgical removal or ablation of their first liver cancer will be monitored with AI-assisted imaging.
This study looks at factors that affect heart health after a liver transplant. It may help doctors better predict and manage heart problems in people with end-stage liver disease who are getting a new liver.
This study examines medical records from patients who received a liver transplant for hepatocellular carcinoma (a type of liver cancer) between 2018 and 2023. The goal is to understand treatment outcomes and improve care for future patients.
This trial uses artificial intelligence to help doctors better stage (classify the severity of) and plan treatment for hepatocellular carcinoma, a type of primary liver cancer. Researchers will collect your clinical information and imaging to see if AI can improve decision-making about your care.
This study is following people who have had a liver, kidney, heart, or lung transplant. It will look for markers in your blood that might help predict how you do in the short and long term after transplant.
Hear when a new Artificial Intelligence (AI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.